{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:15:08Z","timestamp":1780445708951,"version":"3.54.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,6,10]],"date-time":"2017-06-10T00:00:00Z","timestamp":1497052800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s10840-017-0259-1","type":"journal-article","created":{"date-parts":[[2017,6,10]],"date-time":"2017-06-10T01:28:06Z","timestamp":1497058086000},"page":"103-109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Health care utilization among adenosine-sensitive supraventricular tachycardia patients presenting to the emergency department"],"prefix":"10.1007","volume":"49","author":[{"given":"Thomas A.","family":"Dewland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Oesterle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,10]]},"reference":[{"issue":"1","key":"259_CR1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0735-1097(97)00422-1","volume":"31","author":"LA Orejarena","year":"1998","unstructured":"Orejarena LA, Vidaillet H, DeStefano F, Nordstrom DL, Vierkant RA, Smith PN, et al. Paroxysmal supraventricular tachycardia in the general population. J Am Coll Cardiol. 1998;31(1):150\u20137.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"259_CR2","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1197\/j.aem.2007.01.013","volume":"14","author":"DH Murman","year":"2007","unstructured":"Murman DH, McDonald AJ, Pelletier AJ, Camargo CA. U.S. emergency department visits for supraventricular tachycardia, 1993\u20132003. Acad Emerg Med Off J Soc Acad Emerg Med. 2007;14(6):578\u201381.","journal-title":"Acad Emerg Med Off J Soc Acad Emerg Med"},{"key":"259_CR3","unstructured":"Page, R. L., Joglar, J. A., Caldwell, M. A., Calkins, H., Conti, J. B., Deal, B. J., et al. (2015). 2015 ACC\/AHA\/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Journal of the American College of Cardiology."},{"issue":"10","key":"259_CR4","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1056\/NEJMcp051145","volume":"354","author":"E Delacr\u00e9taz","year":"2006","unstructured":"Delacr\u00e9taz E. Clinical practice. Supraventricular tachycardia. N Engl J Med. 2006;354(10):1039\u201351. doi: 10.1056\/NEJMcp051145 .","journal-title":"N Engl J Med"},{"issue":"6","key":"259_CR5","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0002-9343(92)90784-9","volume":"92","author":"AC Rankin","year":"1992","unstructured":"Rankin AC, Brooks R, Ruskin JN, McGovern BA. Adenosine and the treatment of supraventricular tachycardia. Am J Med. 1992;92(6):655\u201364.","journal-title":"Am J Med"},{"issue":"2","key":"259_CR6","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0735-1097(00)01128-1","volume":"37","author":"P Alboni","year":"2001","unstructured":"Alboni P, Tomasi C, Menozzi C, Bottoni N, Paparella N, Fuc\u00e0 G, et al. Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia. J Am Coll Cardiol. 2001;37(2):548\u201353.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"259_CR7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1067\/mhj.2001.115439","volume":"142","author":"M Tendera","year":"2001","unstructured":"Tendera M, Wnuk-Wojnar AM, Kulakowski P, Malolepszy J, Kozlowski JW, Krzeminska-Pakula M, et al. Efficacy and safety of dofetilide in the prevention of symptomatic episodes of paroxysmal supraventricular tachycardia: a 6-month double-blind comparison with propafenone and placebo. Am Heart J. 2001;142(1):93\u20138.","journal-title":"Am Heart J"},{"issue":"4","key":"259_CR8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/0003-4819-96-4-409","volume":"96","author":"DR Mauritson","year":"1982","unstructured":"Mauritson DR, Winniford MD, Walker WS, Rude RE, Cary JR, Hillis LD. Oral verapamil for paroxysmal supraventricular tachycardia: a long-term, double-blind randomized trial. Ann Intern Med. 1982;96(4):409\u201312.","journal-title":"Ann Intern Med"},{"issue":"8","key":"259_CR9","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0002-9149(84)80162-9","volume":"54","author":"MD Winniford","year":"1984","unstructured":"Winniford MD, Fulton KL, Hillis LD. Long-term therapy of paroxysmal supraventricular tachycardia: a randomized, double-blind comparison of digoxin, propranolol and verapamil. Am J Cardiol. 1984;54(8):1138\u20139.","journal-title":"Am J Cardiol"},{"issue":"6","key":"259_CR10","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/0002-9149(94)90747-1","volume":"74","author":"JL Anderson","year":"1994","unstructured":"Anderson JL, Platt ML, Guarnieri T, Fox TL, Maser MJ, Pritchett EL. Flecainide acetate for paroxysmal supraventricular tachyarrhythmias. The Flecainide Supraventricular Tachycardia Study Group. Am J Cardiol. 1994;74(6):578\u201384.","journal-title":"Am J Cardiol"},{"issue":"7","key":"259_CR11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.7326\/0003-4819-114-7-539","volume":"114","author":"EL Pritchett","year":"1991","unstructured":"Pritchett EL, McCarthy EA, Wilkinson WE. Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy. Ann Intern Med. 1991;114(7):539\u201344.","journal-title":"Ann Intern Med"},{"issue":"4","key":"259_CR12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0002-8703(97)70186-8","volume":"133","author":"RS Wanless","year":"1997","unstructured":"Wanless RS, Anderson K, Joy M, Joseph SP. Multicenter comparative study of the efficacy and safety of sotalol in the prophylactic treatment of patients with paroxysmal supraventricular tachyarrhythmias. Am Heart J. 1997;133(4):441\u20136.","journal-title":"Am Heart J"},{"issue":"1","key":"259_CR13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/01.CIR.83.1.119","volume":"83","author":"RW Henthorn","year":"1991","unstructured":"Henthorn RW, Waldo AL, Anderson JL, Gilbert EM, Alpert BL, Bhandari AK, et al. Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study Group. Circulation. 1991;83(1):119\u201325.","journal-title":"Circulation"},{"issue":"3","key":"259_CR14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.7326\/0003-4819-114-3-189","volume":"114","author":"JL Cockrell","year":"1991","unstructured":"Cockrell JL, Scheinman MM, Titus C, Helmy I, Langberg JJ, Lee MA, et al. Safety and efficacy of oral flecainide therapy in patients with atrioventricular re-entrant tachycardia. Ann Intern Med. 1991;114(3):189\u201394.","journal-title":"Ann Intern Med"},{"key":"259_CR15","unstructured":"A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group. (1995). Circulation, 92(9), 2550\u20132557."},{"issue":"1","key":"259_CR16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1161\/01.CIR.83.1.345","volume":"83","author":"DG Benditt","year":"1991","unstructured":"Benditt DG, Dunnigan A, Buetikofer J, Milstein S. Flecainide acetate for long-term prevention of paroxysmal supraventricular tachyarrhythmias. Circulation. 1991;83(1):345\u20139.","journal-title":"Circulation"},{"issue":"5","key":"259_CR17","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0002-9149(98)00416-0","volume":"82","author":"MN Bathina","year":"1998","unstructured":"Bathina MN, Mickelsen S, Brooks C, Jaramillo J, Hepton T, Kusumoto FM. Radiofrequency catheter ablation versus medical therapy for initial treatment of supraventricular tachycardia and its impact on quality of life and healthcare costs. Am J Cardiol. 1998;82(5):589\u201393.","journal-title":"Am J Cardiol"},{"issue":"9","key":"259_CR18","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0002-9149(02)02285-3","volume":"89","author":"AS Goldberg","year":"2002","unstructured":"Goldberg AS, Bathina MN, Mickelsen S, Nawman R, West G, Kusumoto FM. Long-term outcomes on quality-of-life and health care costs in patients with supraventricular tachycardia (radiofrequency catheter ablation versus medical therapy). Am J Cardiol. 2002;89(9):1120\u20133.","journal-title":"Am J Cardiol"},{"issue":"2","key":"259_CR19","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1161\/01.CIR.99.2.262","volume":"99","author":"H Calkins","year":"1999","unstructured":"Calkins H, Yong P, Miller JM, Olshansky B, Carlson M, Saul JP, et al. Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group. Circulation. 1999;99(2):262\u201370.","journal-title":"Circulation"},{"issue":"7","key":"259_CR20","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1161\/01.CIR.94.7.1585","volume":"94","author":"RS Bubien","year":"1996","unstructured":"Bubien RS, Knotts-Dolson SM, Plumb VJ, Kay GN. Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias. Circulation. 1996;94(7):1585\u201391.","journal-title":"Circulation"},{"issue":"3 Pt 1","key":"259_CR21","first-page":"424","volume":"18","author":"CP Lau","year":"1995","unstructured":"Lau CP, Tai YT, Lee PW. The effects of radiofrequency ablation versus medical therapy on the quality-of-life and exercise capacity in patients with accessory pathway-mediated supraventricular tachycardia: a treatment comparison study. Pacing and clinical electrophysiology : PACE. 1995;18(3 Pt 1):424\u201332.","journal-title":"Pacing and clinical electrophysiology : PACE"},{"issue":"2","key":"259_CR22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10840-016-0167-9","volume":"47","author":"MM Farkowski","year":"2016","unstructured":"Farkowski MM, Pytkowski M, Maciag A, Golicki D, Kowalik I, Czech M, et al. Patient\u2019s age rather than severity of the arrhythmia influences the cost of medical treatment of atrioventricular nodal or atrioventricular reciprocating tachycardia. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing. 2016;47(2):197\u2013202.","journal-title":"Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing"},{"issue":"3","key":"259_CR23","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.amjcard.2010.03.035","volume":"106","author":"RN Bukkapatnam","year":"2010","unstructured":"Bukkapatnam RN, Robinson M, Turnipseed S, Tancredi D, Amsterdam E, Srivatsa UN. Relationship of myocardial ischemia and injury to coronary artery disease in patients with supraventricular tachycardia. Am J Cardiol. 2010;106(3):374\u20137.","journal-title":"Am J Cardiol"},{"issue":"5","key":"259_CR24","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ajem.2010.01.041","volume":"29","author":"DJ Carlberg","year":"2011","unstructured":"Carlberg DJ, Tsuchitani S, Barlotta KS, Brady WJ. Serum troponin testing in patients with paroxysmal supraventricular tachycardia: outcome after ED care. Am J Emerg Med. 2011;29(5):545\u20138.","journal-title":"Am J Emerg Med"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10840-017-0259-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-017-0259-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-017-0259-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T18:00:48Z","timestamp":1719252048000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10840-017-0259-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,10]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["259"],"URL":"https:\/\/doi.org\/10.1007\/s10840-017-0259-1","relation":{},"ISSN":["1383-875X","1572-8595"],"issn-type":[{"value":"1383-875X","type":"print"},{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,10]]}}}